Provided by Tiger Trade Technology Pte. Ltd.

DaVita HealthCare Partners

120.51
-0.8450-0.70%
Volume:437.14K
Turnover:52.66M
Market Cap:8.51B
PE:12.34
High:122.40
Open:121.68
Low:118.52
Close:121.35
52wk High:179.60
52wk Low:113.97
Shares:70.60M
Float Shares:34.79M
Volume Ratio:0.86
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.76
EPS(LYR):11.02
ROE:61.62%
ROA:7.01%
PB:-14.88
PE(LYR):10.94

Loading ...

DaVita Q3 2025 Earnings Call Summary and Q&A Highlights: Technology Investments and Volume Recovery

Earnings Call
·
Oct 30

DaVita (DVA) Q3 2025 Earnings Call Transcript

Motley Fool Transcribing
·
Oct 30

Berkshire Hathaway Sold 401,514 Shares of DaVita on October 27, Owned About 31.76 Million Shares of the Kidney Dialysis Services Provider Following the Sale, SEC Filing Shows

THOMSON REUTERS
·
Oct 30

BRIEF-Berkshire Hathaway sells 401,514 DaVita shares, still owns about 31.76 million

Reuters
·
Oct 30

Berkshire Hathaway Inc Reports Open Market Sale of 401,514 DaVita Inc's Common Shares on Oct 27 at $135.3558/Share - SEC Filing

THOMSON REUTERS
·
Oct 30

Berkshire Hathaway Reports Sale of DaVita Inc. Common Shares

Reuters
·
Oct 30

Healthcare provider DaVita's Q3 revenue rises 4.8%

Reuters
·
Oct 30

DaVita Inc. reports $3.42 billion revenue and $150 million net income for Q3 2025

Reuters
·
Oct 30

BRIEF-DaVita Q3 Revenue USD 3,420 Million Vs. IBES Estimate USD 3,428 Million

Reuters
·
Oct 30

DaVita Inc. 3Rd Quarter 2025 Results

THOMSON REUTERS
·
Oct 30

MORNING BID AMERICAS-48 hours to test the exuberance

Reuters
·
Oct 29

Is DaVita’s Advanced Dialysis Research Changing the Investment Case for DVA?

Simply Wall St.
·
Oct 22

DaVita Launches Landmark Studies on Middle-Molecule Clearance in Kidney Failure Patients

Reuters
·
Oct 20

DaVita Inc. to Announce Third Quarter 2025 Results

Reuters
·
Oct 14

DaVita Inc. : Barclays Cuts Target Price to $149 From $160

THOMSON REUTERS
·
Oct 09

DaVita price target lowered to $149 from $160 at Barclays

TIPRANKS
·
Oct 09

DaVita Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Oct 09

Barclays Adjusts Price Target on DaVita to $149 From $160

MT Newswires Live
·
Oct 08

DaVita Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Sep 26

DaVita Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Sep 16